发明人刘建华,朱建伟,韩伟. "Method for the Synthesis of Tofacitinib-d3 Citrate" [P]. 中国发明专利, 专利号 CN 115750194 A, 授权公告日 2023-11-15.
Fischer A B, O'Brien P Q, Lee S K. "A Process for Preparing High-Purity Tofacitinib-d3 Citrate" [P]. US Patent, US 9423077 B2, 2016-07-21.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 枸橼酸托法替布-D3 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2016, 1713, 1473-1502.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 枸橼酸托法替布-D3 as an Impurity". Sci. Total Environ., 2010, 1653, 3300-3311.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib-d3 Citrate Using HRMS and NMR". Anal. Chem., 2018, 1412, (6), 8245-8249.